Floatz logo

FLAVONE, 3,3',4',5,7-PENTAHYDROXY-

Mild Cognitive Impairment

Zaparackas and Knepper LTDSmall moleculePhase 2Active
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
73/ 100

Competitive context

149 Active assets in the Mild Cognitive Impairment cohort.

Asset / SponsorPhaseRating
Ginkgo Biloba Extract
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 4BBB
Rivastigmine
Singapore General Hospital
Phase 4BBB
Nicotine
University of Southern California
Phase 2BBB
Oxybutynin
University of Alberta
Phase 4BBB
Rivastigmine
VA Office of Research and Development
Phase 4BB

View all 50 →

Same molecule, other indications

FLAVONE, 3,3',4',5,7-PENTAHYDROXY- is also rated in:

Myeloma MultipleDormant
BBB
Indicative ·
72 / 100
View asset →
Hepatitis B Virus InfectionDormant
BB
Indicative ·
69 / 100
View asset →
Fanconi anemiaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →